AVIR
Atea Pharmaceuticals, Inc. Common StockstockNASDAQ
Market OpenNov 17, 2026 10:30:16 AM EST
4.07USD-1.214%(-0.05)24,426
AVIR Financials
In Q3 FY 2026 (ended ), Atea Pharmaceuticals, Inc. Common Stock (AVIR) reported net income of −$32.16M, operating cash flow of −$28.87M, and assets of $200.71M (filed ).
Loading financial statements…